Status:
COMPLETED
An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia
Lead Sponsor:
AstraZeneca
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
18+ years
Brief Summary
This study is aimed to collect the following Serbia-specific epidemiology data on hypercholesterolemia: patents characteristics, patients' management/treatment and physicians' standard practice. In ad...
Eligibility Criteria
Inclusion
- Patients with hypercholesterolemia currently receiving a lipid lowering agent
Exclusion
- Pregnancy and lactation.
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT01206231
Start Date
December 1 2010
End Date
October 1 2011
Last Update
November 8 2011
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Belgrade, Serbia
2
Research Site
Čačak, Serbia
3
Research Site
Kamenitz, Serbia
4
Research Site
Kragujevac, Serbia